Campbell, M;
Clarke, A;
Symes, A;
Workman, S;
Stauss, H;
Webster, AD;
(2018)
Investigating the Effectiveness, Acceptability and Impact on Healthcare Usage of Providing a Cognitive-Behavioural Based Psychological Therapy Service for Patients with Primary Antibody Deficiency.
Journal of Clinical Immunology
, 38
pp. 214-220.
10.1007/s10875-018-0481-3.
Preview |
Text
PADS Psychology Manuscript - JoCI Submitted - No Track Changes - 02.02.18.pdf - Accepted Version Download (220kB) | Preview |
Abstract
PURPOSE: Patients with primary antibody deficiency report poorer quality of life and higher rates of anxiety and depression than the general population. Cognitive-behavioral therapy has been shown to be a valuable treatment for patients with other long-term physical health conditions, improving well-being and enabling them to manage their symptoms more effectively. The aim of this project was to establish the feasibility and effectiveness of providing cognitive-behavioral based therapy to patients with primary antibody deficiency. METHODS: Forty-four patients completed a course of psychological therapy. Participants completed a series of self-report measures examining psychological and physical health, and service usage, prior to starting treatment and following their final session. They also provided feedback on their experience of treatment. RESULTS: Patients showed improvements in anxiety, depression, insomnia and fatigue. There was a high level of acceptability of the service and the potential for long-term cost savings to the NHS. CONCLUSION: Psychological therapy based on the cognitive-behavioral model of treatment appears to be a valuable treatment for patients with primary antibody deficiency and comorbid mental health difficulties.
Type: | Article |
---|---|
Title: | Investigating the Effectiveness, Acceptability and Impact on Healthcare Usage of Providing a Cognitive-Behavioural Based Psychological Therapy Service for Patients with Primary Antibody Deficiency |
Location: | Netherlands |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1007/s10875-018-0481-3 |
Publisher version: | http://dx.doi.org/10.1007/s10875-018-0481-3 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
Keywords: | Primary antibody deficiency, cognitive-behavioral therapy, immunoglobulin replacement therapy, mental health, quality of life |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity |
URI: | https://discovery.ucl.ac.uk/id/eprint/10044852 |
Archive Staff Only
View Item |